;PMID: 8825743
;source_file_961.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:44..142] = [t:44..142]
;2)section:[e:146..190] = [t:146..190]
;3)section:[e:194..245] = [t:194..245]
;4)sentence:[e:249..441] = [t:249..441]
;5)sentence:[e:442..626] = [t:442..626]
;6)sentence:[e:627..884] = [t:627..884]
;7)sentence:[e:885..1075] = [t:885..1075]
;8)sentence:[e:1076..1174] = [t:1076..1174]
;9)sentence:[e:1176..1325] = [t:1176..1325]
;10)sentence:[e:1326..1476] = [t:1326..1476]
;11)section:[e:1480..1524] = [t:1480..1524]

;section 0 Span:0..38
;Vet Hum Toxicol. 1996 Feb;38(1):19-23.
(SEC
  (FRAG (NN:[0..3] Vet) (NNP:[4..7] Hum) (NNP:[8..15] Toxicol) (.:[15..16] .)
        (CD:[17..21] 1996) (CC:[22..29] Feb;38-LRB-) (CD:[29..30] 1)
        (-RRB-:[30..31] -RRB-) (CD:[31..34] :19) (::[34..35] -) (CD:[35..37] 23)
        (.:[37..38] .)))

;sentence 1 Span:44..142
;Effects of feeding Artemisia filifolia and Helenium flexuosum on rabbit 
;cytochrome P450 isozymes.
;[63..82]:substance:"Artemisia filifolia"
;[87..105]:substance:"Helenium flexuosum"
;[117..141]:cyp450:"cytochrome P450 isozymes"
(SENT
  (NP-HLN
    (NP (NNS:[44..51] Effects))
    (PP (IN:[52..54] of)
      (S-NOM
        (NP-SBJ (-NONE-:[54..54] *))
        (VP (VBG:[55..62] feeding)
          (NP
            (NP (NNP:[63..72] Artemisia) (NNP:[73..82] filifolia))
            (CC:[83..86] and)
            (NP (NNP:[87..95] Helenium) (NNP:[96..105] flexuosum))))))
    (PP (IN:[106..108] on)
      (NP (NN:[109..115] rabbit)
        
        (NML (NN:[117..127] cytochrome) (NN:[128..132] P450))
        (NNS:[133..141] isozymes)))
    (.:[141..142] .)))

;section 2 Span:146..190
;Eissa FZ, Qualls CW Jr, Burrows GE, Lish JW.
(SEC
  (FRAG (NNP:[146..151] Eissa) (NNP:[152..154] FZ) (,:[154..155] ,)
        (NNP:[156..162] Qualls) (NNP:[163..165] CW) (NNP:[166..168] Jr)
        (,:[168..169] ,) (NNP:[170..177] Burrows) (NNP:[178..180] GE)
        (,:[180..181] ,) (NNP:[182..186] Lish) (NNP:[187..190] JW.)))

;section 3 Span:194..245
;Oklahoma Animal Disease Diagnostic Laboratory, USA.
(SEC
  (FRAG (NNP:[194..202] Oklahoma) (NNP:[203..209] Animal)
        (NNP:[210..217] Disease) (NNP:[218..228] Diagnostic)
        (NNP:[229..239] Laboratory) (,:[239..240] ,) (NNP:[241..244] USA)
        (.:[244..245] .)))

;sentence 4 Span:249..441
;Six groups of 4 rabbits each were treated as follows: Control; phenobarbital 
;(PB); 3-methylcholanthrene (3MC); proadifen hydrochloride (SKF-525A);
;Artemisia  filifolia and Helenium flexuosum.
;[303..310]:substance:"Control"
;[312..325]:substance:"phenobarbital"
;[328..330]:substance:"PB"
;[333..353]:substance:"3-methylcholanthrene"
;[355..358]:substance:"3MC"
;[361..384]:substance:"proadifen hydrochloride"
;[386..394]:substance:"SKF-525A"
;[397..417]:substance:"Artemisia  filifolia"
;[422..440]:substance:"Helenium flexuosum"
(SENT
  (S
    (NP-SBJ-1
      (NP (CD:[249..252] Six) (NNS:[253..259] groups))
      (PP (IN:[260..262] of)
        (NP
          (NP (CD:[263..264] 4) (NNS:[265..272] rabbits))
          (NP (DT:[273..277] each)))))
    (VP (VBD:[278..282] were)
      (VP (VBN:[283..290] treated)
        (NP-1 (-NONE-:[290..290] *))
        (SBAR-ADV (IN:[291..293] as)
          (S
            (NP-SBJ (-NONE-:[293..293] *))
            (VP (VBZ:[294..301] follows) (::[301..302] :)
              (NP
                (NP (NN:[303..310] Control))
                (::[310..311] ;)
                (NP
                  (NP (NN:[312..325] phenobarbital))
                  (NP (-LRB-:[327..328] -LRB-) (NN:[328..330] PB)
                      (-RRB-:[330..331] -RRB-)))
                (::[331..332] ;)
                (NP
                  (NP (NN:[333..353] 3-methylcholanthrene))
                  (NP (-LRB-:[354..355] -LRB-) (NN:[355..358] 3MC)
                      (-RRB-:[358..359] -RRB-)))
                (::[359..360] ;)
                (NP
                   (NN:[361..370] proadifen) (NN:[371..384] hydrochloride)
                  (PRN (-LRB-:[385..386] -LRB-)
                    (NP (NN:[386..394] SKF-525A))
                    (-RRB-:[394..395] -RRB-)))
                (::[395..396] ;)
                (NP
                  (NP (NNP:[397..406] Artemisia) (NNP:[408..417] filifolia))
                  (CC:[418..421] and)
                  (NP (NNP:[422..430] Helenium) (NNP:[431..440] flexuosum)))))))))
    (.:[440..441] .)))

;sentence 5 Span:442..626
;Prototype P450 inducers (PB and 3MC) increased  basal hepatic cytochrome P450
;content by 2-3 fold whereas the P450 inhibitor  (SKF-525A) had no effect on
;basal cytochrome P450 content.
;[452..456]:cyp450:"P450"
;[457..465]:substance:"inducers"
;[467..469]:substance:"PB"
;[474..477]:substance:"3MC"
;[504..519]:cyp450:"cytochrome P450"
;[531..539]:quantitative-value:"2-3 fold"
;[552..556]:cyp450:"P450"
;[557..566]:substance:"inhibitor"
;[569..577]:substance:"SKF-525A"
;[602..617]:cyp450:"cytochrome P450"
(SENT
  (S
    (NP-SBJ (NN:[442..451] Prototype) (NN:[452..456] P450)
            (NNS:[457..465] inducers)
      (PRN (-LRB-:[466..467] -LRB-)
        (NP (NN:[467..469] PB) (CC:[470..473] and) (NN:[474..477] 3MC))
        (-RRB-:[477..478] -RRB-)))
    (VP (VBD:[479..488] increased)
      (NP (JJ:[490..495] basal) (JJ:[496..503] hepatic)
        (NML (NN:[504..514] cytochrome) (NN:[515..519] P450))
        (NN:[520..527] content))
      (PP-EXT (IN:[528..530] by)
        (ADVP
          (QP (CD:[531..532] 2) (HYPH:[532..533] -) (CD:[533..534] 3)
              (RB:[535..539] fold))))
      (SBAR-ADV (IN:[540..547] whereas)
        (S
          (NP-SBJ (DT:[548..551] the) (NN:[552..556] P450)
                  (NN:[557..566] inhibitor)
            (PRN (-LRB-:[568..569] -LRB-)
              (NP (NN:[569..577] SKF-525A))
              (-RRB-:[577..578] -RRB-)))
          (VP (VBD:[579..582] had)
            (NP
              (NP (DT:[583..585] no) (NN:[586..592] effect))
              (PP (IN:[593..595] on)
                (NP (JJ:[596..601] basal)
                  (NML (NN:[602..612] cytochrome) (NN:[613..617] P450))
                  (NN:[618..625] content))))))))
    (.:[625..626] .)))

;sentence 6 Span:627..884
;PB-induction of  hepatic microsomes significantly increased the rate of
;dealkylation of long  alkyl chain alkoxyresorufin ethers, benzyloxyresorufin
;and pentoxyresorufin  47-fold and 17-fold, respectively, but had little or no
;effect on short alkyl  chains.
;[627..629]:substance:"PB"
;[733..755]:substance:"alkoxyresorufin ethers"
;[757..775]:substance:"benzyloxyresorufin"
;[780..796]:substance:"pentoxyresorufin"
;[798..805]:quantitative-value:"47-fold"
;[810..817]:quantitative-value:"17-fold"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[627..629] PB) (HYPH:[629..630] -) (NN:[630..639] induction))
      (PP (IN:[640..642] of)
        (NP (JJ:[644..651] hepatic) (NNS:[652..662] microsomes))))
    (VP
      (VP
        (ADVP (RB:[663..676] significantly))
        (VBD:[677..686] increased)
        (NP
          (NP (DT:[687..690] the) (NN:[691..695] rate))
          (PP (IN:[696..698] of)
            (NP (NN:[699..711] dealkylation)
              (PP (IN:[712..714] of)
                (NP
                  (NP
                    (NML (JJ:[715..719] long) (NN:[721..726] alkyl)
                         (NN:[727..732] chain))
                     (NN:[733..748] alkoxyresorufin) (NNS:[749..755] ethers))
                  (,:[755..756] ,)
                  (NP (NN:[757..775] benzyloxyresorufin) (CC:[776..779] and)
                      (NN:[780..796] pentoxyresorufin)))))))
        (ADVP-EXT
          (ADVP (CD:[798..800] 47) (HYPH:[800..801] -) (RB:[801..805] fold))
          (CC:[806..809] and)
          (ADVP (CD:[810..812] 17) (HYPH:[812..813] -) (RB:[813..817] fold)))
        (,:[817..818] ,)
        (ADVP (RB:[819..831] respectively)))
      (,:[831..832] ,) (CC:[833..836] but)
      (VP (VBD:[837..840] had)
        (NP
          (NP
            (UCP (JJ:[841..847] little) (CC:[848..850] or) (DT:[851..853] no))
            (NN:[854..860] effect))
          (PP (IN:[861..863] on)
            (NP (JJ:[864..869] short) (NN:[870..875] alkyl)
                (NNS:[877..883] chains))))))
    (.:[883..884] .)))

;sentence 7 Span:885..1075
;3MC-induction of microsomes increased dealkylation of all  alkoxyresorufin
;ethers tested, preferentially dealkylating ethers with short  alkyl chain in
;the order: methoxy > ethoxy > propoxy.
;[885..888]:substance:"3MC"
;[944..966]:substance:"alkoxyresorufin ethers"
;[1003..1009]:substance:"ethers"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[885..888] 3MC) (HYPH:[888..889] -) (NN:[889..898] induction))
      (PP (IN:[899..901] of)
        (NP (NNS:[902..912] microsomes))))
    (VP
      (VP (VBD:[913..922] increased)
        (NP
          (NP (NN:[923..935] dealkylation))
          (PP (IN:[936..938] of)
            (NP
              (NP (DT:[939..942] all)
                 (NN:[944..959] alkoxyresorufin) (NNS:[960..966] ethers))
              (VP (VBN:[967..973] tested)
                (NP (-NONE-:[973..973] *)))))))
      (,:[973..974] ,)
      (VP
        (ADVP (RB:[975..989] preferentially))
        (VBG:[990..1002] dealkylating)
        (NP
          (NP (NNS:[1003..1009] ethers))
          (PP (IN:[1010..1014] with)
            (NP (JJ:[1015..1020] short) (NN:[1022..1027] alkyl)
                (NN:[1028..1033] chain))))
        (PP (IN:[1034..1036] in)
          (NP
            (NP (DT:[1037..1040] the) (NN:[1041..1046] order))
            (::[1046..1047] :)
            (NP
              (NP (JJ:[1048..1055] methoxy))
              (PP (SYM:[1056..1057] >)
                (NP
                  (NP (JJ:[1058..1064] ethoxy))
                  (PP (SYM:[1065..1066] >)
                    (NP (JJ:[1067..1074] propoxy))))))))))
    (.:[1074..1075] .)))

;sentence 8 Span:1076..1174
;Artemisia filifolia or  Helenium flexuosum had no effect on basal hepatic
;cytochrome P450 content.
;[1076..1095]:substance:"Artemisia filifolia"
;[1100..1118]:substance:"Helenium flexuosum"
;[1150..1165]:cyp450:"cytochrome P450"
(SENT
  (S
    (NP-SBJ
      (NP (NNP:[1076..1085] Artemisia) (NNP:[1086..1095] filifolia))
      (CC:[1096..1098] or)
      (NP (NNP:[1100..1108] Helenium) (NNP:[1109..1118] flexuosum)))
    (VP (VBD:[1119..1122] had)
      (NP
        (NP (DT:[1123..1125] no) (NN:[1126..1132] effect))
        (PP (IN:[1133..1135] on)
          (NP (JJ:[1136..1141] basal) (JJ:[1142..1149] hepatic)
            (NML (NN:[1150..1160] cytochrome) (NN:[1161..1165] P450))
            (NN:[1166..1173] content)))))
    (.:[1173..1174] .)))

;sentence 9 Span:1176..1325
;However, microsomal dealkylation activity of short alkyl chain
;alkoxyresorufin  ethers (methoxy, ethoxy and propoxy) was inhibited
;approximately 50%.
;[1239..1262]:substance:"alkoxyresorufin  ethers"
;[1321..1324]:quantitative-value:"50%"
(SENT
  (S
    (ADVP (RB:[1176..1183] However))
    (,:[1183..1184] ,)
    (NP-SBJ-1
      (NP (JJ:[1185..1195] microsomal) (NN:[1196..1208] dealkylation)
          (NN:[1209..1217] activity))
      (PP (IN:[1218..1220] of)
        (NP
          (NML (JJ:[1221..1226] short) (NN:[1227..1232] alkyl)
               (NN:[1233..1238] chain))
           (NN:[1239..1254] alkoxyresorufin) (NNS:[1256..1262] ethers)
          (PRN (-LRB-:[1263..1264] -LRB-)
            (NP (JJ:[1264..1271] methoxy) (,:[1271..1272] ,)
                (JJ:[1273..1279] ethoxy) (CC:[1280..1283] and)
                (JJ:[1284..1291] propoxy))
            (-RRB-:[1291..1292] -RRB-)))))
    (VP (VBD:[1293..1296] was)
      (VP (VBN:[1297..1306] inhibited)
        (NP-1 (-NONE-:[1306..1306] *))
        (NP-EXT
          (QP (RB:[1307..1320] approximately) (CD:[1321..1323] 50))
          (NN:[1323..1324] %))))
    (.:[1324..1325] .)))

;sentence 10 Span:1326..1476
;When these  plants are eaten for several days, they may inhibit
;biotransformation processes  in herbivores through the same isoenzymes
;induced by 3MC.
;[1450..1460]:substance:"isoenzymes"
;[1472..1475]:substance:"3MC"
(SENT
  (S
    (SBAR-ADV
      (WHADVP-2 (WRB:[1326..1330] When))
      (S
        (NP-SBJ-1 (DT:[1331..1336] these) (NNS:[1338..1344] plants))
        (VP (VBP:[1345..1348] are)
          (VP (VBN:[1349..1354] eaten)
            (NP-1 (-NONE-:[1354..1354] *))
            (PP-TMP (IN:[1355..1358] for)
              (NP (JJ:[1359..1366] several) (NNS:[1367..1371] days)))
            (ADVP-TMP-2 (-NONE-:[1371..1371] *T*))))))
    (,:[1371..1372] ,)
    (NP-SBJ (PRP:[1373..1377] they))
    (VP (MD:[1378..1381] may)
      (VP (VB:[1382..1389] inhibit)
        (NP (NN:[1390..1407] biotransformation) (NNS:[1408..1417] processes))
        (PP-LOC (IN:[1419..1421] in)
          (NP (NNS:[1422..1432] herbivores)))
        (PP (IN:[1433..1440] through)
          (NP
            (NP (DT:[1441..1444] the) (JJ:[1445..1449] same)
                (NNS:[1450..1460] isoenzymes))
            (VP (VBN:[1461..1468] induced)
              (NP (-NONE-:[1468..1468] *))
              (PP (IN:[1469..1471] by)
                (NP-LGS (NN:[1472..1475] 3MC))))))))
    (.:[1475..1476] .)))

;section 11 Span:1480..1524
;PMID: 8825743 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1480..1484] PMID) (::[1484..1485] :) (CD:[1486..1493] 8825743)
        (NN:[1494..1495] -LSB-) (NNP:[1495..1501] PubMed) (::[1502..1503] -)
        (NN:[1504..1511] indexed) (IN:[1512..1515] for)
        (NNP:[1516..1524] MEDLINE-RSB-)))
